Navigation Links
Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
Date:10/12/2010

CHAPEL HILL, N.C., Oct. 12 /PRNewswire/ -- Cempra Pharmaceuticals announced that Richard Kent, M.D., a partner at Intersouth Partners, has been appointed to Cempra's board of directors.  Dr. Kent will replace Garheng Kong, M.D., Ph.D., M.B.A., as Intersouth's representative on the board.   Dr. Kong, who has recently taken a position as a general partner at Sofinnova Ventures, will continue as Cempra's chairman of the board.

Dr. Kent brings extensive pharmaceutical management and drug development experience to the Cempra board.  During his over 25 years in the pharmaceutical industry, he supervised dozens of Investigational New Drug (IND) applications and over 20 successful New Drug Applications (NDAs) in a wide range of therapeutic areas.  Prior to joining Intersouth Partners, he was chief executive officer of Serenex, Inc., a venture-backed biotechnology company that was acquired by Pfizer in 2008.  He also held a number of senior positions at Burroughs Wellcome, GlaxoWellcome and GlaxoSmithKline.  Dr. Kent received his M.D. from the University of California, San Diego and his B.Sc. from the University of California, Berkeley.

"Adding Dr. Kent to our board, with his experience both in shepherding NDAs through to regulatory approval and his involvement with Serenex's transaction with Pfizer, is an important step for Cempra," said Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra Pharmaceuticals.  "We have two differentiated antibiotic candidates in mid-to-late stage clinical development.  His advice will be invaluable as both of our antibiotics move forward towards an NDA as well as assisting us with our partnering strategy."

Dr. Kent added, "Cempra's two antibiotic candidates have significant commercial potential in a therapeutic area that needs new options for physicians and patients but suffers from a lack of new drug candidates.  I am looking forward to working with
'/>"/>

SOURCE Cempra Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Data Presented on Cempra Pharmaceuticals CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates
2. Presentations of Cempra Pharmaceuticals CEM-102 (fusidic acid) at the Infectious Diseases Society of America Annual Meeting Highlight Properties That Make It an Excellent Anti-MRSA Candidate
3. Cempra Pharmaceuticals To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17th
4. Cempra Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
5. Cempra Pharmaceuticals to Present at the UBS Global Life Sciences Conference
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Oct. 31, 2014  Lycera Corp., a biopharmaceutical ... autoimmune disease and cancer, today announced that data ... agonist product candidates will be presented at the ... Cancer (SITC) being held November 6-9, 2014 at ... Harbor, MD.  The poster, entitled " Novel synthetic ...
(Date:10/31/2014)... , Oct. 31, 2014 ThynkWare ( www.thynkware.com ... patients initiate text and email messages using their thoughts. ... technology invented by ThynkWare,s founder, Duane Cash , ... smartphone device. This technology allows users to control their ... power of thought. ThynkWare provides the interface ...
(Date:10/31/2014)... LAVAL, QC , Oct. 31, 2014 /CNW Telbec/ ... is poised, with its strategic plan, for accelerated growth ... 2014 was 32.6% and revenues reached $17,862,341. Net income ... $3 million threshold for the first time in the ... this growth, the Company joined the forces of its ...
Breaking Medicine Technology:Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2Results for the fourth quarter and the fiscal year ended June 30, 2014 - Ergoresearch reports solid 2014 annual results 2Results for the fourth quarter and the fiscal year ended June 30, 2014 - Ergoresearch reports solid 2014 annual results 3Results for the fourth quarter and the fiscal year ended June 30, 2014 - Ergoresearch reports solid 2014 annual results 4Results for the fourth quarter and the fiscal year ended June 30, 2014 - Ergoresearch reports solid 2014 annual results 5
... CHICAGO and NEW YORK, Dec. 6, 2010 With as ... developing Alzheimer,s,(1) the Alzheimer,s Association and Pfizer (NYSE: ... disease by emphasizing to all Americans, "It,s Time to Face ... related to their personal experience with the disease in an ...
... Following the annual meeting of its stockholders on Friday, ... ) announced that its stockholders approved the reappointment of ... C. Wallen as directors of the Company.  In addition, ... PricewaterhouseCoopers LLP as its independent registered public accounting firm. ...
Cached Medicine Technology:National Initiative Urges 10 Million At-Risk Boomers to 'Face Alzheimer's' 2National Initiative Urges 10 Million At-Risk Boomers to 'Face Alzheimer's' 3National Initiative Urges 10 Million At-Risk Boomers to 'Face Alzheimer's' 4Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm 2Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm 3
(Date:10/31/2014)... to life. The last stage, when two daughter cells ... dawn of cell biology in the Victorian era. For ... study this final step, when the dividing cell creates ... given to this process by those early biologists, cytokinesis, ... a highly active and organized series of events. Scientists ...
(Date:10/31/2014)... — A team from the Broad Institute, the ... California, Santa Cruz, was awarded one of three ... contracts with the goal of building a system ... Genome Atlas (TCGA) and other datasets by co-locating ... one cloud environment. This co-location will enable researchers ...
(Date:10/31/2014)... CA (PRWEB) October 31, 2014 ... also has amazing health effects for practitioners. ... by a Doctor of Science and Movement specializing ... his dedication to pelvic floor reeducation that traditional ... urinary incontinence, Diastasis Recti, Prolepses, etc. , The ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Energy Textiles ... gear. The new gear is now available online, and ... the benefits of Celliant infrared-active athletic gear over compression ... that another contract has been signed for Under Armour ... for the next eight years. In light of this ...
(Date:10/31/2014)... treatment and cost, patients with early stage breast ... (APBI) with proton therapy versus whole breast irradiation ... of Texas MD Anderson Proton Therapy Center. ... on typical patient characteristics, researchers used Medicare reimbursement ... types of partial and whole breast irradiation therapies ...
Breaking Medicine News(10 mins):Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 2Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 3Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3
... America,s pharmaceutical research companies are testing 109 medicines and ... to a report released today by the Pharmaceutical Research and ... anniversary of "World AIDS Day" - a global awareness campaign ... Health on Programmes for AIDS Prevention. , ...
... allows patients to control their own pain medication, but a new ... Commission Journal on Quality and Patient Safety shows that errors ... in patient harm than errors that occur with other medications. ... than 9,500 PCA errors over a five-year period in the United ...
... for HIV Prevention, Calls on Governments to Increase Investment in ... (Para tener acceso a una copia completa de la declaracion ... , WASHINGTON, Dec. 1 An ... Latina women in the United States is demanding increased access ...
... ARCADIS family of products highlights the cutting-edge of intraoperative imaging ... Siemens Healthcare ( ... family of next-generation ARCADIS(R) C-Arm systems, featuring outstanding image quality, ... 94th Scientific Assembly and Annual Meeting of the Radiological Society ...
... independent study at the,University of Cumbria found that nine in every ... exercising. The games reduce the boredom of,exercise. , ... to use exercise equipment,combined with video games provided by a company ... could play their games only while they maintained movement on,the fitness ...
... Appear in Upcoming TV Commercial - , , ... Whitening Expressions is "FanTaste-ic!" Crest Whitening Expressions and flavor expert ... contest in search of a new catch phrase that best ... "FanTaste-ic" was selected from over 600 contest entries, and America voted ...
Cached Medicine News:Health News:109 Medicines and Vaccines Now in Development for HIV/AIDS 2Health News:109 Medicines and Vaccines Now in Development for HIV/AIDS 3Health News:Study: Patient Harm More Common with Patient-Controlled Pain Medication 2Health News:Study: Patient Harm More Common with Patient-Controlled Pain Medication 3Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 2Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 3Health News:Siemens Next-Generation of C-Arms Demonstrate Precision Imaging and Ease of Use 2Health News:Siemens Next-Generation of C-Arms Demonstrate Precision Imaging and Ease of Use 3Health News:Children Tell Researchers: We'll Get Fit if It's Fun 2Health News:Video: America Votes Crest Whitening Expressions Is FanTaste-ic! 2
... Immunoassay (EIA) IgG & IgM Test System is ... presumptive detection of human IgG & IgM antibodies ... system should be used to test serum from ... with B. burgdorferi. All positive and equivocal specimens ...
... TheraTears in a bottle becomes preservative-free ... turns into oxygen and water on ... eyes with mild to moderate dryness ... maintenance treatment. Now you can have ...
... sutures are prepared by coating the ... caprolactone/glycolide copolymer and calcium stearoyl lactylate. ... increase visibility and are also available ... established by the United States Pharmacopeia ...
... QualiCode™ B. burgdorferi IgG/IgM Western Blot Kits ... detection of antibodies to Borrelia burgdorferi. Proteins ... disruption. Purified B. burgdorferi antigens are fractionated ... a polyacrylamide slab gel in the presence ...
Medicine Products: